Human Metabolome Technologies, Inc. (TYO:6090)
Japan · Delayed Price · Currency is JPY 625.00
0.00 (0.00%)
Aug 27, 2026, 3:30 PM JST
TYO:6090 Balance Sheet
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 1,444 | 1,562 | 1,788 | 1,656 | 1,504 |
Cash & Short-Term Investments | 1,444 | 1,562 | 1,788 | 1,656 | 1,504 |
Cash Growth | -7.55% | -12.64% | 7.97% | 10.11% | 20.80% |
Receivables | 258 | 171 | 228 | 129 | 158 |
Inventory | 27 | 51 | 36 | 26 | 43 |
Other Current Assets | 38 | 80 | 43 | 37 | 36 |
Total Current Assets | 1,767 | 1,864 | 2,095 | 1,848 | 1,741 |
Property, Plant & Equipment | 264 | 284 | 331 | 270 | 243 |
Long-Term Investments | 55 | 55 | 12 | 14 | 13 |
Other Intangible Assets | 33 | 12 | 17 | 21 | 6 |
Long-Term Deferred Tax Assets | 159 | 157 | 146 | 136 | 64 |
Other Long-Term Assets | 2 | 2 | 2 | 2 | 1 |
Total Assets | 2,280 | 2,374 | 2,603 | 2,291 | 2,068 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 22 | 3 | 15 | - | - |
Accrued Expenses | 77 | 89 | 86 | 83 | 77 |
Short-Term Debt | 100 | 100 | 200 | 200 | 200 |
Current Portion of Leases | 3 | 7 | 14 | 13 | 9 |
Current Income Taxes Payable | 139 | 114 | 214 | 87 | 161 |
Other Current Liabilities | 97 | 136 | 103 | 110 | 99 |
Total Current Liabilities | 438 | 449 | 632 | 493 | 546 |
Long-Term Leases | - | 3 | 11 | 13 | 23 |
Other Long-Term Liabilities | 14 | 15 | 15 | 14 | 14 |
Total Liabilities | 452 | 467 | 658 | 520 | 583 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 1,488 | 1,488 | 1,487 | 1,484 | 1,481 |
Additional Paid-In Capital | 7 | 7 | 6 | 3 | 1,470 |
Retained Earnings | 699 | 585 | 417 | 233 | -1,522 |
Treasury Stock | -350 | -166 | - | - | - |
Comprehensive Income & Other | -16 | -7 | 35 | 51 | 56 |
Shareholders' Equity | 1,828 | 1,907 | 1,945 | 1,771 | 1,485 |
Total Liabilities & Equity | 2,280 | 2,374 | 2,603 | 2,291 | 2,068 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 103 | 110 | 225 | 226 | 232 |
Net Cash (Debt) | 1,341 | 1,452 | 1,563 | 1,430 | 1,272 |
Net Cash Growth | -7.65% | -7.10% | 9.30% | 12.42% | 16.38% |
Net Cash Per Share | 238.98 | 247.26 | 264.33 | 242.17 | 215.59 |
Filing Date Shares Outstanding | 5.51 | 5.68 | 5.92 | 5.91 | 5.9 |
Total Common Shares Outstanding | 5.51 | 5.69 | 5.92 | 5.91 | 5.9 |
Working Capital | 1,329 | 1,415 | 1,463 | 1,355 | 1,195 |
Book Value Per Share | 331.69 | 335.02 | 328.79 | 299.81 | 251.69 |
Tangible Book Value | 1,795 | 1,895 | 1,928 | 1,750 | 1,479 |
Tangible Book Value Per Share | 325.70 | 332.91 | 325.92 | 296.26 | 250.67 |
Order Backlog | - | 573.86 | 610.42 | 433.22 | 401.36 |